Autoimmune Mechanisms Activating the Angiotensin AT1 Receptor in 'Primary' Aldosteronism
Author(s) -
David C. Kem,
Hongliang Li,
Carolina VelardeMiranda,
Campbell Liles,
Megan VanderlindeWood,
Allison Galloway,
Muneer Khan,
Caitlin Zillner,
Alexandria Benbrook,
Veitla Rao,
Celso E. Gómez-Sánchez,
Madeleine W. Cunningham,
Xichun Yu
Publication year - 2014
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2013-3282
Subject(s) - losartan , medicine , endocrinology , aldosterone , autoantibody , angiotensin ii , angiotensin ii receptor type 1 , renin–angiotensin system , primary aldosteronism , receptor , pathophysiology , immunology , antibody , blood pressure
The mechanisms causing excessive aldosterone production and hypertension in primary aldosteronism (PA) are complex and often incompletely recognized. Autoantibodies to the angiotensin AT1 receptor (AT1R) have been reported in some PA patients with an aldosterone-producing adenoma but not with idiopathic adrenal hyperplasia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom